Carsten Denkert

40PUBLICATIONS
287CO-AUTHORS
Predictive and prognostic markersMolecular targetsPalliative careCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 11, 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|Apr 29, 2026
Challenges and strategies for delivering effective breast cancer care in conflict zones.

|Apr 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

|Aug 05, 2025
Report of a national external quality assessment program for HER2-low expression in breast cancer-options for increased accuracy with standardized methodology.

Carsten Denkert, Florian Sperling, Anika Pehl

|Jul 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer.

Sofya Marchenko, Niklas Goernitz, Wiebke A Zoern

Pageof 7

Frequent Collaborators

22 joint publications

Sibylle Loibl

15 joint publications

Peter Fasching

14 joint publications

Valentina Nekljudova

13 joint publications

Michael Untch